INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF"

GENEVA, April 18 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/060228) for "GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF" on Oct 09, 2025. With publication no. WO/2026/078617, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEVI, Samuel Michael (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), MARTINEZ-ALSINA, Luis Angel (c/o Pfizer Inc.445 Eastern Point RoadBuilding 98Groton, Connecticut 06340), PUL...